The impact of depression and fluoxetine treatment on obstetrical outcome

被引:1
|
作者
Suri R. [1 ,4 ]
Altshuler L. [1 ]
Hendrick V. [1 ]
Rasgon N. [2 ]
Lee E. [1 ]
Mintz J. [3 ]
机构
[1] Department of Psychiatry, UCLA Neuropsychiat. Inst. and Hosp., Los Angeles, CA
[2] Department of Psychiatry, Stanford University, Palo Alto, CA
[3] Department of Psychiatry, W. Los Angeles Vet. Admin. Med. Ctr., Los Angeles, CA
[4] UCLA Neuropsychiat. Inst. and Hosp., Los Angeles, CA 90095
关键词
Depression; Fluoxetine; Obstetrical/neonatal outcome; Pregnancy;
D O I
10.1007/s00737-004-0057-5
中图分类号
学科分类号
摘要
Introduction: This study prospectively followed women over the course of pregnancy to assess the impact of depression and/or antidepressant treatment on obstetrical outcome. Method: Sixty-four outpatient women with an Axis I diagnosis of major depressive disorder or no psychiatric history were followed in each trimester of pregnancy with administration of the CES-D. A subset of the women with depression received treatment with fluoxetine during pregnancy. Subjects with a CES-D score greater than 16 at any time point were further assessed for the presence of an active major or minor depressive episode. Primary outcome variables included infant gestational age, birth weight, Apgar score, and admission to the neonatal intensive care unit. Results: Analyzable data were available for 62 women. No significant differences were found in outcome variables between those women with exposure to medication and/or prenatal depressed mood and those women without a history of depression. Conclusions: In contrast to other studies, our study did not demonstrate an adverse effect of fluoxetine exposure per se on obstetrical outcome. In addition, we did not find a significant impact of depression during pregnancy on obstetrical outcome.
引用
收藏
页码:193 / 200
页数:7
相关论文
共 50 条
  • [31] FLUOXETINE VERSUS TRAZODONE IN THE TREATMENT OF OUTPATIENTS WITH MAJOR DEPRESSION
    DEBUS, JR
    RUSH, J
    HIMMEL, C
    TYLER, D
    POLATIN, P
    WEISSENBURGER, J
    JOURNAL OF CLINICAL PSYCHIATRY, 1988, 49 (11) : 422 - 426
  • [32] Olanzapine-fluoxetine combination for the treatment of bipolar depression
    Citrome, Leslie
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (17) : 2751 - 2758
  • [33] Neurophysiologic predictors of treatment response to fluoxetine in major depression
    Cook, IA
    Leuchter, AF
    Witte, E
    Abrams, M
    Uijtdehaage, SHJ
    Stubbeman, W
    Rosenberg-Thompson, S
    Anderson-Hanley, C
    PSYCHIATRY RESEARCH, 1999, 85 (03) : 263 - 273
  • [34] Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram?
    Khazaie, Habibolah
    Rahimi, Mehrali
    Tatari, Faeze
    Rezaei, Mansour
    Najafi, Farid
    Tahmasian, Masoud
    NEUROSCIENCES, 2011, 16 (01) : 42 - 45
  • [35] Fluoxetine in the treatment of alcohol addicts with comorbid major depression
    Vukovic, O
    Pavlovic, Z
    Maric, N
    Jasovic-Gasic, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S30 - S30
  • [36] Fluoxetine versus trimipramine in the treatment of depression in geriatric patients
    Wehmeier, PM
    Kluge, M
    Maras, A
    Riemann, D
    Berger, M
    Kohnen, R
    Dittmann, RW
    Gattaz, WF
    PHARMACOPSYCHIATRY, 2005, 38 (01) : 13 - 16
  • [37] Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline
    Russell, JM
    Berndt, ER
    Miceli, R
    Colucci, S
    Grudzinski, AN
    AMERICAN JOURNAL OF MANAGED CARE, 1999, 5 (05): : 597 - 606
  • [38] MOCLOBEMIDE VERSUS FLUOXETINE IN THE TREATMENT OF IN PATIENTS WITH MAJOR DEPRESSION
    GATTAZ, WF
    VOGEL, P
    KICK, H
    KOHNEN, R
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (04) : S35 - S40
  • [39] FLUOXETINE TREATMENT OF DEPRESSION IN PATIENTS WITH HIV-INFECTION
    PERKINS, DO
    EVANS, DL
    AMERICAN JOURNAL OF PSYCHIATRY, 1991, 148 (06): : 807 - 808
  • [40] Fluoxetine treatment in patients with Recurrent Brief Depression (RBD)
    Stamenkovic, M
    Blasbichler, T
    Brandstätter, N
    Pezawas, L
    Aschauer, HN
    Kasper, S
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 93S - 93S